Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Marin

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Proceedings of the National Academy of Sciences of the United States of America|March 9, 2022
Induction of broadly neutralizing antibodies using a secreted form of the hepatitis C virus E1E2 heterodimer as a vaccine candidateRuixue Wang, Saori Suzuki, Johnathan D Guest, et al.
Journal of Virology|September 4, 2020
Structure-Based Design of Hepatitis C Virus E2 Glycoprotein Improves Serum Binding and Cross-NeutralizationBrian G Pierce, Zhen-Yong Keck, Ruixue Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 12, 2021
Design of a native-like secreted form of the hepatitis C virus E1E2 heterodimerJohnathan D Guest, Ruixue Wang, Khadija H Elkholy, et al.
Biorxiv : the Preprint Server for Biology|April 28, 2025
Glycoengineering of the hepatitis C virus E2 glycoprotein leads to improved biochemical properties and enhanced immunogenicityLiudmila Kulakova, Kiki H Li, Austin W T Chiang, et al.
NPJ Vaccines|June 11, 2025
Glycoengineering of the hepatitis C virus E2 glycoprotein improves biochemical properties and enhances immunogenicityLiudmila Kulakova, Kiki H Li, Austin W T Chiang, et al.
Nature Communications|December 22, 2025
Rational design of flavivirus E protein vaccine optimizes immunogenicity and mitigates antibody dependent enhancement riskYimeng Wang, Andrey Galkin, Xiaoran Shang, et al.
Nature Communications|June 12, 2020
A cancer drug atlas enables synergistic targeting of independent drug vulnerabilitiesRavi S Narayan, Piet Molenaar, Jian Teng, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Proceedings of the National Academy of Sciences of the United States of America|March 9, 2022
Induction of broadly neutralizing antibodies using a secreted form of the hepatitis C virus E1E2 heterodimer as a vaccine candidateRuixue Wang, Saori Suzuki, Johnathan D Guest, et al.
Journal of Virology|September 4, 2020
Structure-Based Design of Hepatitis C Virus E2 Glycoprotein Improves Serum Binding and Cross-NeutralizationBrian G Pierce, Zhen-Yong Keck, Ruixue Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 12, 2021
Design of a native-like secreted form of the hepatitis C virus E1E2 heterodimerJohnathan D Guest, Ruixue Wang, Khadija H Elkholy, et al.
Biorxiv : the Preprint Server for Biology|April 28, 2025
Glycoengineering of the hepatitis C virus E2 glycoprotein leads to improved biochemical properties and enhanced immunogenicityLiudmila Kulakova, Kiki H Li, Austin W T Chiang, et al.
NPJ Vaccines|June 11, 2025
Glycoengineering of the hepatitis C virus E2 glycoprotein improves biochemical properties and enhances immunogenicityLiudmila Kulakova, Kiki H Li, Austin W T Chiang, et al.
Nature Communications|December 22, 2025
Rational design of flavivirus E protein vaccine optimizes immunogenicity and mitigates antibody dependent enhancement riskYimeng Wang, Andrey Galkin, Xiaoran Shang, et al.
Nature Communications|June 12, 2020
A cancer drug atlas enables synergistic targeting of independent drug vulnerabilitiesRavi S Narayan, Piet Molenaar, Jian Teng, et al.
Pageof 5